Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Artesunate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 335Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amivas’s Artesunate Injection Approved in Canada
    Amivas’s Artesunate Injection Approved in Canada

    04 Jul 2025

    // HEALTH CANADA

    https://pdf.hres.ca/dpd_pm/00080986.PDF

    HEALTH CANADA
    04 Jul 2025
    Share Share
    Mangalam Drugs expanding anti-malaria APl portfolio with Pyronaridine
    Mangalam Drugs expanding anti-malaria APl portfolio with Pyronaridine

    21 Aug 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/mangalam-drugs-organics-expanding-anti-malaria-apl-portfolio-with-introduction-of-pyronaridine-16056

    INDIANPHARMAPOST
    21 Aug 2024
    Share Share
    Amivas' Artesunate Amivas (artesunate) Receives Approval in Europe
    Amivas' Artesunate Amivas (artesunate) Receives Approval in Europe

    23 Aug 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/artesunate-amivas-epar-medicine-overview_en.pdf

    EMA
    23 Aug 2023
    Share Share
    AMIVAS Ireland Receives Authorisation from MHRA to Market Artesunate Amivas
    AMIVAS Ireland Receives Authorisation from MHRA to Market Artesunate Amivas

    13 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/amivas-ireland-ltd-receives-authorisation-from-the-medicines--healthcare-products-regulatory-agency-mhra-to-market-artesunate-amivas-artesunate-in-uk-for-initial-treatment-of-severe-malaria-301566099.html

    PRNEWSWIRE
    13 Jun 2022
    Share Share
    EU Commission Grants AMIVAS Ireland Ltd. Approval to Market artesunate
    EU Commission Grants AMIVAS Ireland Ltd. Approval to Market artesunate

    24 Nov 2021

    // ADNKRONOS

    https://www.adnkronos.com/eu-commission-grants-amivas-ireland-ltd-approval-to-market-artesunate-amivas-artesunate-in-the-eueea-for-initial-treatment-of-severe-malaria_rrElf2EIbqGM6RLWng5gN

    ADNKRONOS
    24 Nov 2021
    Share Share
    Enforcement Report - Week of October 13, 2021
    Enforcement Report - Week of October 13, 2021

    13 Oct 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-13-2021-1634124785.pdf

    FDA
    13 Oct 2021
    Share Share